Financials

  • Market Capitalization 194.3 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.34
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3629
SLGL
Sol-Gel Technologies Ltd. - Ordinary Shares
70.43 USD+1.31%-12.45%-13.58%+194.19%196.23 M USD
3630
CUE
Cue Biopharma, Inc. - Common Stock
26.96 USD-5.20%-2.81%-0.33%+3312.66%195.85 M USD
3660
LENZ
LENZ Therapeutics, Inc. - Common Stock
5.80 USD+10.90%+21.34%+14.85%-82.15%182.24 M USD
3675
KRRO
Korro Bio, Inc. - Common Stock
11.97 USD-2.21%-12.11%+9.52%-69.23%176.27 M USD

新闻